CLINICAL_TRIALS
trial_result
· 2015-05-12
Clinical Trial Update: Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial [Phase 4]
Summary
A 48-week Phase 4 trial comparing golimumab versus pamidronate for axial spondyloarthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tuen Mun Hospital | Conditions: Spondyloarthropathy | Phase 4 | Status: COMPLETED